Select language
Knowledge Base
Transparency in Every Detail
We believe an informed patient is a successful patient. Explore our clinical database of common hair restoration questions.
Technology & Innovation
ICEFUE (Ice Follicular Unit Extraction) involves a specialized 3-stage cold-chain preservation protocol. Once hair follicles are extracted, they are placed in a patented pressurized cooling chamber maintained at exactly -4°C. This sub-zero environment triggers a state of hibernation, pausing the biological aging of the grafts and preventing cellular stress. This process is similar to the principles used in organ transplantation to maintain absolute biological integrity.
Yes, ICEFUE holds global intellectual property patents for its specific graft preservation chamber and thermal-shielded implantation tools. This ensures that only official ICEFUE franchise clinics can provide the specific sub-zero survival benefits associated with our brand.
Procedure & Comfort
The procedure is performed under high-precision local anesthesia. Most patients report feeling minimal discomfort only during the initial numbing phase. Once the area is anesthetized, the procedure is entirely pain-free. At ICEFUE, we also utilize needle-free pressure-anesthesia for patients with needle phobias.
Depending on the number of grafts required, a session typically lasts between 6 to 8 hours. This includes the extraction phase, a clinical break for the patient, and the precise implantation phase.
Results & Recovery
The transplanted hair usually goes through a "shedding" phase at 3-4 weeks. Significant regrowth begins at 3-6 months. Most patients see 80% of their final density at month 9, with the full, mature 98% survival result visible at month 12.
Yes! ICEFUE is a graft preservation technology that works with any extraction or implantation method. You can choose Sapphire FUE + ICEFUE or DHI + ICEFUE for maximum survival results.
Financial & Clinical Efficiency
While ICEFUE may cost 10-20% more upfront due to the specialized clinical equipment and biological exosome solutions, you obtain 15-20% more surviving grafts. This significantly improves final density and often avoids the high cost and downtime of a corrective second procedure, making it more cost-effective in the long term.
Still have questions?
Our medical consultants are ready to provide a personalized analysis of your specific case.
Ask a Medical Consultant Ask a Medical Consultant